TY - JOUR
T1 - The role of cyclooxygenase-derived oxidative stress in surgically induced lymphedema in a mouse tail model
AU - Chang, Ting Chen
AU - Uen, Yih Huei
AU - Chou, Cheng Hung
AU - Sheu, Joen Rong
AU - Chou, Duen Suey
PY - 2013/5
Y1 - 2013/5
N2 - Context: Oxidative stress may contribute to lymphedema and subsequent tissue damage. However, the causal role of oxidative stress in lymphedema remains unclear. Objective: We attempted to detect and identify the free radicals formed in lymphedema fluid and assessed the protective mechanisms and effects of specific enzyme inhibitors and natural antioxidants. Materials and methods: To study the level of postsurgical oxidative stress with lymphedema in a mouse tail model, we used an electron spin resonance (ESR) method and an ascorbyl radical's ESR spectrum as an oxidative stress biomarker. The drug-treatment group received an i.p. injection with indomethacin (2mg/kg), baicalein (15mg/kg), MK-886 (3mg/kg), zileuton (6.25mg/kg), diphenyleneiodonium (DPI; 1mg/kg), sulforaphane (30mg/kg), oryzanol (30mg/kg) or sesamol (30mg/kg) once daily for 14d from the day of operation. All animals were sacrificed on day 14. Results: Administration of indomethacin, sulforaphane, oryzanol and sesamol significantly suppressed both the tail volume (56.9%, 77.8%, 72.2% and 38.1% inhibition, respectively, p<0.01) and ascorbyl radical signals (31.4%, 54.5%, 79.3% and 57.1% inhibition, respectively, p<0.01), compared with the control mice. No significant differences were found between any of the baicalein, MK-886, or zileuton groups compared with the control. DPI suppressed the tail volume (25.9% inhibition, p<0.01) but not the ascorbyl radical signals. Conclusion: This study showed that COX-derived oxidative stress plays a major role in the pathological mechanisms of surgically induced lymphedema. Indomethacin, sulforaphane, oryzanol and sesamol exhibit potent protective properties against surgically induced lymphedema.
AB - Context: Oxidative stress may contribute to lymphedema and subsequent tissue damage. However, the causal role of oxidative stress in lymphedema remains unclear. Objective: We attempted to detect and identify the free radicals formed in lymphedema fluid and assessed the protective mechanisms and effects of specific enzyme inhibitors and natural antioxidants. Materials and methods: To study the level of postsurgical oxidative stress with lymphedema in a mouse tail model, we used an electron spin resonance (ESR) method and an ascorbyl radical's ESR spectrum as an oxidative stress biomarker. The drug-treatment group received an i.p. injection with indomethacin (2mg/kg), baicalein (15mg/kg), MK-886 (3mg/kg), zileuton (6.25mg/kg), diphenyleneiodonium (DPI; 1mg/kg), sulforaphane (30mg/kg), oryzanol (30mg/kg) or sesamol (30mg/kg) once daily for 14d from the day of operation. All animals were sacrificed on day 14. Results: Administration of indomethacin, sulforaphane, oryzanol and sesamol significantly suppressed both the tail volume (56.9%, 77.8%, 72.2% and 38.1% inhibition, respectively, p<0.01) and ascorbyl radical signals (31.4%, 54.5%, 79.3% and 57.1% inhibition, respectively, p<0.01), compared with the control mice. No significant differences were found between any of the baicalein, MK-886, or zileuton groups compared with the control. DPI suppressed the tail volume (25.9% inhibition, p<0.01) but not the ascorbyl radical signals. Conclusion: This study showed that COX-derived oxidative stress plays a major role in the pathological mechanisms of surgically induced lymphedema. Indomethacin, sulforaphane, oryzanol and sesamol exhibit potent protective properties against surgically induced lymphedema.
KW - Ascorbyl radical
KW - Electron spin resonance
KW - Indomethacin
KW - Oryzanol
KW - Sesamol
KW - Sulforaphane
UR - http://www.scopus.com/inward/record.url?scp=84876555567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876555567&partnerID=8YFLogxK
U2 - 10.3109/13880209.2012.749923
DO - 10.3109/13880209.2012.749923
M3 - Article
C2 - 23373707
AN - SCOPUS:84876555567
SN - 1388-0209
VL - 51
SP - 573
EP - 580
JO - Pharmaceutical Biology
JF - Pharmaceutical Biology
IS - 5
ER -